Diabetes Management in Pocatello: A Functional Medicine Approach

Type 2 diabetes is one of the most common conditions we manage at Roth Family Medicine — and one of the most mismanaged in conventional medicine.

The standard approach goes something like this: A patient's fasting glucose or A1C crosses a threshold. They're diagnosed with type 2 diabetes or prediabetes. They're counseled to "eat less and exercise more." They're started on metformin. If their numbers don't improve, more medications are added. The focus is almost entirely on managing blood sugar numbers — not on understanding or addressing why blood sugar is elevated in the first place.

This approach keeps patients medicated but rarely reverses the underlying condition. And type 2 diabetes is, in many cases, reversible.

A functional medicine approach to diabetes asks different questions: Why is this person insulin resistant? What are the root causes driving their metabolic dysfunction? What needs to change — not just in their medication list, but in their diet, lifestyle, gut health, hormones, and environment — to restore metabolic health?

Type 2 diabetes is fundamentally a disease of insulin resistance — not simply high blood sugar. Understanding this distinction is critical to understanding why conventional management often falls short.

Here's what actually happens in type 2 diabetes:

1. Insulin resistance develops — cells (primarily in muscle, liver, and fat tissue) become less responsive to insulin's signal to take up glucose
2. The pancreas compensates — it produces more insulin to overcome the resistance, keeping blood sugar normal for years
3. Hyperinsulinemia — chronically elevated insulin levels drive fat storage, inflammation, and further insulin resistance
4. Pancreatic beta cell exhaustion — eventually, the pancreas can no longer keep up with the demand for excess insulin
5. Blood sugar rises — first postprandially (after meals), then fasting — and the diagnosis of prediabetes or diabetes is made

By the time blood sugar is elevated enough to diagnose diabetes, insulin resistance has typically been present for 10–15 years. The blood sugar elevation is a late-stage symptom, not the disease itself.

If insulin resistance is the root problem, then treatments that only lower blood sugar without addressing insulin resistance are treating the symptom, not the disease. Metformin, for example, lowers blood sugar primarily by reducing hepatic glucose production — but it doesn't fundamentally reverse insulin resistance in muscle and fat tissue.

A functional medicine approach targets insulin resistance directly — through dietary change, exercise, sleep optimization, stress reduction, gut health, and addressing specific root causes.

Insulin resistance doesn't develop randomly. It has identifiable causes — and addressing them is the foundation of functional medicine diabetes management.

The most powerful driver of insulin resistance is diet — specifically, a diet high in refined carbohydrates, added sugar, and ultra-processed foods.

Refined carbohydrates and sugar cause rapid blood glucose spikes that require large insulin responses. Over time, chronically elevated insulin drives insulin receptor downregulation — the cells literally reduce the number of insulin receptors on their surface in response to constant insulin stimulation.

Fructose (from added sugar and high-fructose corn syrup) is particularly problematic. Unlike glucose, fructose is metabolized almost entirely in the liver, where it is converted to fat (de novo lipogenesis), driving non-alcoholic fatty liver disease (NAFLD) and hepatic insulin resistance.

Industrial seed oils (soybean, corn, canola, sunflower) are high in omega-6 fatty acids and promote systemic inflammation, which worsens insulin resistance.

Skeletal muscle is the primary site of glucose disposal — accounting for 70–80% of insulin-stimulated glucose uptake. Physical inactivity reduces muscle mass and impairs the GLUT4 transporter system that moves glucose into muscle cells.

Exercise — particularly resistance training and high-intensity interval training (HIIT) — is one of the most powerful interventions for insulin resistance, independent of weight loss.

Visceral fat (fat stored around the abdominal organs, as opposed to subcutaneous fat) is metabolically active and pro-inflammatory. It releases free fatty acids and inflammatory cytokines that directly impair insulin signaling in the liver and muscle.

Waist circumference is a better predictor of metabolic risk than BMI. Men with waist circumference > 40 inches and women > 35 inches are at significantly elevated risk.

Even a single night of poor sleep impairs insulin sensitivity by 20–25%. Chronic sleep deprivation is a major and underappreciated driver of insulin resistance.

Sleep deprivation:

• Elevates cortisol and growth hormone (both counter-regulatory hormones that raise blood sugar)
• Increases ghrelin (hunger hormone) and decreases leptin (satiety hormone)
• Promotes fat storage and muscle breakdown
• Impairs glucose tolerance

Obstructive sleep apnea — extremely common in people with type 2 diabetes — causes repeated nocturnal hypoxia and cortisol surges that worsen insulin resistance. Treating sleep apnea often produces meaningful improvements in blood sugar control.

Cortisol is a counter-regulatory hormone that raises blood sugar by stimulating hepatic glucose production and promoting insulin resistance. Chronic psychological stress, with its sustained cortisol elevation, is a significant driver of metabolic dysfunction.

The stress-diabetes connection is bidirectional: stress worsens blood sugar control, and poor blood sugar control increases stress and anxiety.

The gut microbiome plays a significant role in metabolic health. People with type 2 diabetes have distinct microbiome profiles compared to metabolically healthy individuals — with reduced diversity, fewer butyrate-producing bacteria, and increased inflammatory species.

Gut dysbiosis promotes:

• Increased intestinal permeability ("leaky gut")
• Systemic endotoxemia (bacterial lipopolysaccharides entering the bloodstream)
• Chronic low-grade inflammation
• Impaired GLP-1 production (the gut hormone that stimulates insulin secretion)

Several micronutrients are critical for insulin signaling and glucose metabolism:

• Magnesium: Required for insulin receptor function; deficiency is extremely common in type 2 diabetes and worsens insulin resistance
• Vitamin D: Vitamin D receptors are present on pancreatic beta cells; deficiency impairs insulin secretion and sensitivity
• Chromium: Enhances insulin receptor signaling; deficiency impairs glucose tolerance
• Zinc: Required for insulin synthesis and storage in the pancreas
• B vitamins: Metformin depletes B12; deficiency causes neuropathy that may be misattributed to diabetic neuropathy

Endocrine-disrupting chemicals (EDCs) — including BPA, phthalates, pesticides, and persistent organic pollutants — interfere with insulin signaling and are associated with higher rates of type 2 diabetes. These chemicals accumulate in fat tissue and are released during weight loss, which may partly explain why weight loss sometimes worsens metabolic markers initially.

Hypothyroidism reduces metabolic rate, promotes weight gain, and impairs glucose metabolism. Thyroid dysfunction is common and often missed in patients with type 2 diabetes. We routinely screen thyroid function in all patients with metabolic syndrome or diabetes.

At Roth Family Medicine, our diabetes evaluation goes well beyond a standard A1C and fasting glucose. We assess:

Glycemic markers:

• Fasting glucose and A1C
• Fasting insulin (to assess insulin resistance directly)
• HOMA-IR (calculated from fasting glucose and insulin)
• Postprandial glucose (1- and 2-hour glucose after a standard meal)

Metabolic markers:

• Comprehensive lipid panel (including LDL particle size and number — small dense LDL is far more atherogenic than large fluffy LDL)
• Triglycerides and triglyceride:HDL ratio (a powerful marker of insulin resistance)
• Uric acid (elevated in insulin resistance and metabolic syndrome)
• Liver function tests (NAFLD is present in up to 70% of people with type 2 diabetes)

Inflammatory markers:

• High-sensitivity CRP
• Homocysteine
• Fibrinogen

Nutritional assessment:

• Vitamin D
• Magnesium (RBC)
• B12 (especially if on metformin)
• Zinc
• Ferritin

Hormonal assessment:

• Thyroid panel (TSH, free T3, free T4, TPO antibodies)
• Cortisol (morning and evening, or 4-point salivary)
• Testosterone (low testosterone is strongly associated with insulin resistance in men)
• DHEA-S

Gut health:

• Comprehensive stool analysis (when gut symptoms are present)
• Organic acids testing (for dysbiosis markers)

Diet is the most powerful tool for reversing insulin resistance. The specific approach depends on the individual, but several dietary strategies have strong evidence:

Low-carbohydrate and ketogenic diets produce the most rapid improvements in blood sugar and insulin levels. By dramatically reducing carbohydrate intake, these diets reduce the glucose load that drives insulin secretion and allow insulin levels to fall. Multiple studies show that low-carbohydrate diets can produce A1C reductions of 1–2% — comparable to adding a second diabetes medication.

Time-restricted eating (intermittent fasting) — eating within a 6–10 hour window — allows insulin levels to fall during the fasting period, improving insulin sensitivity and promoting metabolic flexibility (the ability to switch between glucose and fat as fuel).

Mediterranean diet — while not as aggressively carbohydrate-restricted as ketogenic diets, the Mediterranean diet reduces inflammation, improves lipid profiles, and produces meaningful improvements in glycemic control.

Elimination of ultra-processed foods and added sugar is non-negotiable regardless of the specific dietary approach.

Exercise is one of the most powerful interventions for insulin resistance — and it works through mechanisms that are independent of weight loss.

Resistance training builds muscle mass, increasing the body's glucose disposal capacity. Even modest increases in muscle mass produce meaningful improvements in insulin sensitivity.

High-intensity interval training (HIIT) activates GLUT4 transporters in muscle cells through an insulin-independent pathway, allowing glucose uptake even in the presence of insulin resistance.

Post-meal walking — even a 10-minute walk after meals — significantly blunts postprandial glucose spikes.

The goal: at least 150 minutes of moderate-intensity exercise per week, with 2–3 sessions of resistance training.

Treating sleep disorders — particularly obstructive sleep apnea — is a high-yield intervention for metabolic health. We screen all patients with type 2 diabetes for sleep apnea and refer for sleep study when indicated.

Sleep hygiene optimization: consistent sleep and wake times, dark and cool bedroom, limiting screens before bed, avoiding alcohol (which fragments sleep architecture).

Chronic stress management is essential for metabolic health. We discuss:

• Mindfulness and meditation practices
• Regular physical activity (which reduces cortisol)
• Social connection and support
• Addressing underlying anxiety and depression (which are extremely common in type 2 diabetes and worsen glycemic control)

Based on individual testing, we may recommend:

• Magnesium glycinate: 200–400mg daily (improves insulin sensitivity)
• Vitamin D: 2,000–5,000 IU daily (optimize to 50–80 ng/mL)
• Berberine: 500mg 2–3x daily (comparable to metformin in some studies for glucose lowering)
• Alpha-lipoic acid: 600mg daily (improves insulin sensitivity and reduces oxidative stress)
• Chromium picolinate: 200–400mcg daily (enhances insulin receptor signaling)
• B12: Essential if on metformin (which depletes B12)
• Omega-3 fatty acids: 2–4g EPA+DHA daily (reduces inflammation and triglycerides)

We don't avoid medications — we use them strategically, in combination with lifestyle interventions, and with an eye toward their metabolic effects.

Metformin remains a reasonable first-line medication for most patients with type 2 diabetes. It's inexpensive, well-tolerated, and has cardiovascular benefits beyond glucose lowering. We monitor B12 levels in all patients on metformin.

GLP-1 receptor agonists (semaglutide/Ozempic, liraglutide/Victoza, tirzepatide/Mounjaro) are among the most powerful tools we have for type 2 diabetes. They reduce blood sugar, promote weight loss, reduce cardiovascular events, and protect kidney function. For patients with established cardiovascular disease or high cardiovascular risk, these medications are often first-line.

SGLT-2 inhibitors (empagliflozin/Jardiance, dapagliflozin/Farxiga) lower blood sugar by causing the kidneys to excrete glucose in the urine. They also have significant cardiovascular and kidney-protective benefits and promote modest weight loss.

Insulin is sometimes necessary — particularly for patients with significant beta cell dysfunction — but we aim to use it as a last resort after optimizing lifestyle and trying other medications.

Yes — in many cases. The evidence is clear: significant dietary change, weight loss (particularly visceral fat loss), and exercise can produce complete remission of type 2 diabetes in a substantial proportion of patients.

The landmark DiRECT trial found that 46% of participants achieved remission (A1C < 6.5% without diabetes medications) at 1 year with an intensive dietary intervention, and 36% maintained remission at 2 years.

Remission is most likely in patients who:

• Have had diabetes for less than 6 years
• Have lost significant weight (particularly visceral fat)
• Have preserved beta cell function (C-peptide testing can assess this)
• Are highly adherent to dietary and lifestyle changes

Even patients who don't achieve full remission can dramatically reduce their medication burden, improve their quality of life, and reduce their risk of complications.

At Roth Family Medicine & Mental Health, we offer comprehensive, functional medicine-informed diabetes care that goes beyond standard management. We work with you to:

• Identify the root causes of your insulin resistance
• Develop a personalized dietary and lifestyle plan
• Optimize nutritional status through targeted testing and supplementation
• Use medications strategically — and work toward reducing them when possible
• Address the mental health dimensions of diabetes (depression and anxiety are twice as common in people with diabetes)
• Monitor comprehensively — not just A1C, but the full metabolic picture

Whether you've just been diagnosed with prediabetes or have been managing type 2 diabetes for years, there is more that can be done. The goal isn't just to manage your numbers — it's to restore your metabolic health.

Call us at (208) 904-4705 or visit us at 444 Hospital Way, Suite 422, Pocatello, Idaho 83201 to schedule a comprehensive metabolic evaluation.

Kyle Roth, FNP-BC, APRN, MSN, MHA is a board-certified family nurse practitioner specializing in functional medicine, integrative mental health, and comprehensive primary care at Roth Family Medicine & Mental Health in Pocatello, Idaho.